These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 14586741)

  • 21. Salutary effect of pigment epithelium-derived factor in diabetic nephropathy: evidence for antifibrogenic activities.
    Wang JJ; Zhang SX; Mott R; Knapp RR; Cao W; Lau K; Ma JX
    Diabetes; 2006 Jun; 55(6):1678-85. PubMed ID: 16731830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpression of connective tissue growth factor in podocytes worsens diabetic nephropathy in mice.
    Yokoi H; Mukoyama M; Mori K; Kasahara M; Suganami T; Sawai K; Yoshioka T; Saito Y; Ogawa Y; Kuwabara T; Sugawara A; Nakao K
    Kidney Int; 2008 Feb; 73(4):446-55. PubMed ID: 18075496
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Connective tissue growth factor mediates high glucose effects on matrix degradation through tissue inhibitor of matrix metalloproteinase type 1: implications for diabetic nephropathy.
    McLennan SV; Wang XY; Moreno V; Yue DK; Twigg SM
    Endocrinology; 2004 Dec; 145(12):5646-55. PubMed ID: 15345671
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of protein kinase C beta isoform activation on the gene expression of transforming growth factor-beta, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats.
    Koya D; Jirousek MR; Lin YW; Ishii H; Kuboki K; King GL
    J Clin Invest; 1997 Jul; 100(1):115-26. PubMed ID: 9202063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of diabetic nephropathy in rats by prostaglandin E receptor EP1-selective antagonist.
    Makino H; Tanaka I; Mukoyama M; Sugawara A; Mori K; Muro S; Suganami T; Yahata K; Ishibashi R; Ohuchida S; Maruyama T; Narumiya S; Nakao K
    J Am Soc Nephrol; 2002 Jul; 13(7):1757-65. PubMed ID: 12089371
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CTGF mediates TGF-beta-induced fibronectin matrix deposition by upregulating active alpha5beta1 integrin in human mesangial cells.
    Weston BS; Wahab NA; Mason RM
    J Am Soc Nephrol; 2003 Mar; 14(3):601-10. PubMed ID: 12595495
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Smad pathway is activated in the diabetic mouse kidney and Smad3 mediates TGF-beta-induced fibronectin in mesangial cells.
    Isono M; Chen S; Hong SW; Iglesias-de la Cruz MC; Ziyadeh FN
    Biochem Biophys Res Commun; 2002 Sep; 296(5):1356-65. PubMed ID: 12207925
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of catalpol on diabetic nephropathy in rats.
    Dong Z; Chen CX
    Phytomedicine; 2013 Aug; 20(11):1023-9. PubMed ID: 23746755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro evidence for differential involvement of CTGF, TGFbeta, and PDGF-BB in mesangial response to injury.
    Blom IE; van Dijk AJ; Wieten L; Duran K; Ito Y; Kleij L; deNichilo M; Rabelink TJ; Weening JJ; Aten J; Goldschmeding R
    Nephrol Dial Transplant; 2001 Jun; 16(6):1139-48. PubMed ID: 11390712
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CTGF expression in mesangial cells: involvement of SMADs, MAP kinase, and PKC.
    Chen Y; Blom IE; Sa S; Goldschmeding R; Abraham DJ; Leask A
    Kidney Int; 2002 Oct; 62(4):1149-59. PubMed ID: 12234285
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of advanced glycation end products on renal fibrosis and oxidative stress in cultured NRK-49F cells.
    Yan HD; Li XZ; Xie JM; Li M
    Chin Med J (Engl); 2007 May; 120(9):787-93. PubMed ID: 17531120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CTGF inhibits BMP-7 signaling in diabetic nephropathy.
    Nguyen TQ; Roestenberg P; van Nieuwenhoven FA; Bovenschen N; Li Z; Xu L; Oliver N; Aten J; Joles JA; Vial C; Brandan E; Lyons KM; Goldschmeding R
    J Am Soc Nephrol; 2008 Nov; 19(11):2098-107. PubMed ID: 18632843
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of connective tissue growth factor in renal tubular epithelial-myofibroblast transdifferentiation and extracellular matrix accumulation in vitro.
    Zhang C; Meng X; Zhu Z; Yang X; Deng A
    Life Sci; 2004 Jun; 75(3):367-79. PubMed ID: 15135656
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kinetics of connective tissue growth factor expression during experimental proliferative glomerulonephritis.
    Ito Y; Goldschmeding R; Bende RJ; Claessen N; Chand MA; Kleij L; Rabelink TJ; Weening JJ; Aten J
    J Am Soc Nephrol; 2001 Mar; 12(3):472-484. PubMed ID: 11181795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Connective tissue growth factor (CTGF/CCN2) is a downstream mediator for TGF-beta1-induced extracellular matrix production in osteoblasts.
    Arnott JA; Nuglozeh E; Rico MC; Arango-Hisijara I; Odgren PR; Safadi FF; Popoff SN
    J Cell Physiol; 2007 Mar; 210(3):843-52. PubMed ID: 17133352
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Connective tissue growth factor is involved in pancreatic repair and tissue remodeling in human and rat acute necrotizing pancreatitis.
    di Mola FF; Friess H; Riesle E; Koliopanos A; Büchler P; Zhu Z; Brigstock DR; Korc M; Büchler MW
    Ann Surg; 2002 Jan; 235(1):60-7. PubMed ID: 11753043
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endoglin expression regulates basal and TGF-beta1-induced extracellular matrix synthesis in cultured L6E9 myoblasts.
    Obreo J; Díez-Marques L; Lamas S; Düwell A; Eleno N; Bernabéu C; Pandiella A; López-Novoa JM; Rodríguez-Barbero A
    Cell Physiol Biochem; 2004; 14(4-6):301-10. PubMed ID: 15319534
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Connective tissue growth factor is associated with the early renal hypertrophy in uninephrectomized diabetic rats.
    Liu BC; Huang HQ; Luo DD; Ma KL; Liu DG; Liu H
    Chin Med J (Engl); 2006 Jun; 119(12):1010-6. PubMed ID: 16805985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glomerular expression of CTGF, TGF-beta 1 and type IV collagen in diabetic nephropathy.
    Umezono T; Toyoda M; Kato M; Miyauchi M; Kimura M; Maruyama M; Honma M; Yagame M; Suzuki D
    J Nephrol; 2006; 19(6):751-7. PubMed ID: 17173248
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spironolactone ameliorates renal injury and connective tissue growth factor expression in type II diabetic rats.
    Han KH; Kang YS; Han SY; Jee YH; Lee MH; Han JY; Kim HK; Kim YS; Cha DR
    Kidney Int; 2006 Jul; 70(1):111-20. PubMed ID: 16723984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.